Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study will be conducted in three parallel groups receiving oxycodone, levodopa or placebo, administered as an add-on therapy, in addition to the usual antiparkinsonian treatment. As this study focuses on chronic central neuropathic pain caused by PD, the effects of study treatments will be evaluated after a 10-week treatment period
Epistemonikos ID: b72713420f0f17a118b16f3671112a46460b00d2
First added on: May 12, 2024